Concurrent Langerhans Cell Histiocytosis and KMT2A-Rearranged Acute Myeloid Leukemia Showing Dual Response to Azacitidine
Current Genetic Medicine Reports · 18.06.2026 · 14 (1)
DOI: 10.1007/s40142-026-00249-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Genetic Medicine Reports, online erschienen am 18.06.2026. Verfasst von Derya Demirtas und 10 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Demirtas, D., Arikan, F., Erbilgin, Y., Tekin, M. F., Candan, O., Yanik, A. M., Yilmaz, A. F., Atagunduz, I., Bozkurt, S., Tuglular, A. T., & Toptas, T. (2026). Concurrent Langerhans Cell Histiocytosis and KMT2A-Rearranged Acute Myeloid Leukemia Showing Dual Response to Azacitidine. Current Genetic Medicine Reports, 14(1). https://doi.org/10.1007/s40142-026-00249-2
Vancouver
Demirtas D, Arikan F, Erbilgin Y, Tekin MF, Candan O, Yanik AM, et al. Concurrent Langerhans Cell Histiocytosis and KMT2A-Rearranged Acute Myeloid Leukemia Showing Dual Response to Azacitidine. Current Genetic Medicine Reports. 2026;14(1). doi:10.1007/s40142-026-00249-2
BibTeX
@article{Demirtas2026,
author = {Demirtas, Derya and Arikan, Fatma and Erbilgin, Yucel and Tekin, Mehmet Fatih and Candan, Ozlem and Yanik, Ahmet Mert and Yilmaz, Asu Fergun and Atagunduz, Isik and Bozkurt, Suheyla and Tuglular, Ayse Tulin and Toptas, Tayfur},
title = {Concurrent Langerhans Cell Histiocytosis and KMT2A-Rearranged Acute Myeloid Leukemia Showing Dual Response to Azacitidine},
journal = {Current Genetic Medicine Reports},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40142-026-00249-2}
}
EUVIMED